chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: Severe headache; Nausea; Myalgia; sore/itchy throat; Sore/itchy throat; Fever and chills within 3-4 post vaccination; Fever and chills within 3-4 post vaccination; This is a spontaneous report from a contactable healthcare professional who reported for herself, a 21-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), intramuscular in the right arm, on 30Jan2021 at 18:30, at the age of 21 years, at a single dose for COVID-19 immunization. Medical history included asthma, and known allergies to azithromycin (ZITHROMAX) and sulfa. The patient was not pregnant, and not pregnant at time of vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. On 30Jan2021 at 21:30, the patient experienced fever and chills within 3-4 post vaccination. The patient experienced severe headache, nausea, myalgia, and sore/itchy throat the next day, on 31Jan2021. No treatment was received for the events. Patient had no COVID prior vaccination, and was not COVID tested post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Throat irritation
Clinical narrative: Severe headache; Nausea; Myalgia; sore/itchy throat; Sore/itchy throat; Fever and chills within 3-4 post vaccination; Fever and chills within 3-4 post vaccination; This is a spontaneous report from a contactable healthcare professional who reported for herself, a 21-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), intramuscular in the right arm, on 30Jan2021 at 18:30, at the age of 21 years, at a single dose for COVID-19 immunization. Medical history included asthma, and known allergies to azithromycin (ZITHROMAX) and sulfa. The patient was not pregnant, and not pregnant at time of vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. On 30Jan2021 at 21:30, the patient experienced fever and chills within 3-4 post vaccination. The patient experienced severe headache, nausea, myalgia, and sore/itchy throat the next day, on 31Jan2021. No treatment was received for the events. Patient had no COVID prior vaccination, and was not COVID tested post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain
Clinical narrative: Headaches; Chills/shivering; Nauseated; Body aches; This is a spontaneous report from a contactable consumer (patient) reported that a 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Jan2021 11:00 at a single dose for Covid-19 immunization.  The patient's medical history and concomitant medications were not reported. After dinner of 30Jan2021, the patient started having symptoms listed as headaches, chills, nauseated, and body aches. She described her chills as being so bad that she woke up last night shivering. She said the nausea and body aches come and go. She asked how long will her symptoms last. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Off label use, Pain
Clinical narrative: Severe body aches and headaches 12 hours after administration of 2nd dose.; Severe body aches and headaches 12 hours after administration of 2nd dose.; First dose's administration date 13Jan2021, second dose's administration date: 30Jan2021; First dose's administration date 13Jan2021, second dose's administration date: 30Jan2021; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9262, expiry date: not reported), via an unspecified route of administration at left arm on 30Jan2021 at SINGLE DOSE for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history included polycystic ovary syndrome (PCOS), gilbert's syndrome, bipolar disorder, and allergies to sulfa. The patient received unspecified concomitant medication received within 2 weeks of vaccination. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL1283), at left arm on 13Jan2021 at 06:30 PM for COVID-19 Immunisation. On 31Jan2021 at 04:30 AM, the patient experienced severe body aches and headaches 12 hours after administration of 2nd dose. The reporter considered the events non-serious. There was no treatment received for the events. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The outcome of the events severe body aches and headaches was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Runny nose; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included citalopram hydrobromide (CELEXA). The patient experienced runny nose on 29Jan2021 08:00. No therapeutic measure was taken as a result of the event. Clinical outcome of the event was recovering.   Information on the lot/batch number has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: the injection site is still slightly pink and itches several times a day/ it was a little tender to touch; the injection site is still slightly pink and itches several times a day/ it was a little tender to touch; the injection site is still slightly pink and itches several times a day/ it was a little tender to touch; This is a spontaneous report from a contactable consumer (reporting for herself). A 68-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EL 1284, expiration date unknown) via an unspecified route of administration in the left arm on 17Jan2021 19:00 (at 68 years old) at a SINGLE DOSE for COVID-19 immunization. The patient was vaccinated in other vaccination facility. Medical history included controlled high blood pressure and allergies to Asprin and Acetaminophen, all from an unknown date. Patient was not pregnant at the time of vaccination. Concomitant medications included calcium, diltiazem 280, lisinopril, and "AREDS." The patient received these medications within 2 weeks of vaccination. The patient was not diagnosed with COVID prior to vaccination, did not receive any other vaccines within 4 weeks prior to BNT162B2, and has not been tested for COVID post vaccination. The patient reported that the adverse events started on 17Jan2021. It's been two (2) weeks since her first vaccine, and the injection site is still slightly pink and itches several times a day. At first, she thought it was a bug bite. It was a little tender to touch. Outcome of the events was recovering. The events were reported as Non-serious.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired/very tired; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265, expiry date: unknown), via an unspecified route of administration on 28Jan2021 13:45 (at the age of 81 years old) at a single dose in the left arm for covid-19 immunisation. Medical history included obesity. The patient's concomitant medications were not reported. The patient is not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with covid-19 prior to vaccination and has not been tested for covid-19 since the vaccination. The patient had no known allergies. On 30Jan2021, the patient experienced tired and following day very tired from which she slept five hours during the day. The patient did not receive any treatment for the event. Outcome of the event was unknown. Event was reported as non-serious.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Chest discomfort, Chest pain, Decreased appetite, Dyspnoea
Clinical narrative: Couldn't take a full breath. Most intense standing or laying down, lesser when seated/when exercising like I can't take a big enough breathe; Centralized chest pain on sternum.; Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak; Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak; Arm soreness; Nauseous all week; loss of appetite; Sore to touch; heavy chested; medical history included Hashimoto's; medical history included Hashimoto's; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318; expiration date not provided), via an unspecified route of administration on 25Jan2021 19:00 at SINGLE DOSE for COVID-19 immunisation. Patient's medical history included Hashimoto's, asthma, and food allergy all from unknown dates and unknown if ongoing. The patient has no COVID prior vaccination. The patient was not COVID tested post vaccination. Patient is not pregnant. Concomitant medications included levothyroxine sodium, liothyronine sodium, progesteron, and sertraline. Adverse events on 26Jan2021 at 07:00 were reported as follows: Centralized chest pain on sternum. Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak (patient reported that she has asthma). Sore to touch. Couldn't take a full breath, most intense standing or laying down, lesser when seated. Lasted just over 48 hours. Patient also stated, 'Still feel heavy chested when exercising like I can't take a big enough breathe'. Patient also reported arm soreness, nauseous all week, loss of appetite. Also on period. The patient has not received treatment for the events. Outcome of the events was reported as 'Recovered with lasting effects'.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Nausea, Pain, Pain in extremity
Clinical narrative: Couldn't take a full breath. Most intense standing or laying down, lesser when seated/when exercising like I can't take a big enough breathe; Centralized chest pain on sternum.; Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak; Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak; Arm soreness; Nauseous all week; loss of appetite; Sore to touch; heavy chested; medical history included Hashimoto's; medical history included Hashimoto's; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318; expiration date not provided), via an unspecified route of administration on 25Jan2021 19:00 at SINGLE DOSE for COVID-19 immunisation. Patient's medical history included Hashimoto's, asthma, and food allergy all from unknown dates and unknown if ongoing. The patient has no COVID prior vaccination. The patient was not COVID tested post vaccination. Patient is not pregnant. Concomitant medications included levothyroxine sodium, liothyronine sodium, progesteron, and sertraline. Adverse events on 26Jan2021 at 07:00 were reported as follows: Centralized chest pain on sternum. Felt extremely heavy, not like a regular flu. More like as asthma attack that was waiting to peak (patient reported that she has asthma). Sore to touch. Couldn't take a full breath, most intense standing or laying down, lesser when seated. Lasted just over 48 hours. Patient also stated, 'Still feel heavy chested when exercising like I can't take a big enough breathe'. Patient also reported arm soreness, nauseous all week, loss of appetite. Also on period. The patient has not received treatment for the events. Outcome of the events was reported as 'Recovered with lasting effects'.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pain
Clinical narrative: lightheaded; tired; achy; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 22Jan2021 19:00 at a single dose for Covid-19 immunization. Medical history included borderline hypertension and allergies to latex. Patient was not pregnant. Concomitant medications included atorvastatin, lisinopril, and fish oil. The patient previously took morphine and had allergy. Patient reported that the day after the vaccination, she experienced lightheaded, tired, and achy at 2pm on 23Jan2021. She had these symptoms every day since. Some days it happens more often than others.  It happens at different times such as lying down, walking, etc. No treatment was given. Outcome of the events was not recovered.  Information regarding the lot/batch number has been requested.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: 103 fever; Chills; horrible headache; This is a spontaneous report from a contactable consumer (patient). A 20-year-old male patient received first single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration (vaccine location: left arm) on 30Jan2021 15:45 for Covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: School or Student Health Clinic. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. On 31Jan2021, the patient experienced chills, horrible headache and 103 fever. The events were considered as non-serious by the reporter. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was not recovered.  Information on the lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Vaccination site pain
Clinical narrative: Bad headache; pain at location of injection; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number E13302), via an unspecified route of administration (arm right) on 15Jan2021 11:30 SINGLE DOSE for covid-19 immunisation, at 42 years old. Medical history reported as none. The patient is not pregnant. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient has no reported allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI FE), therapy date and indication unknown (received withing 2 weeks).  The patient experienced bad headache lasting over 24 hours, pain at location of injection for two days, and diarrhea on 15Jan2021 11:30. Treatment was not given. Outcome of the events was recovered on Jan2021. The reporter considered the events as non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Hypoaesthesia, Paraesthesia, SARS-CoV-2 test
Clinical narrative: numbness and tingling in her neck - radiating to the pinnae of her ears, bilateral shoulders and to bilateral upper and lower extremities (BUE and BLE); felt acutely short of breath and anxious; felt acutely short of breath and anxious; numbness and tingling in her neck - radiating to the pinnae of her ears, bilateral shoulders and to bilateral upper and lower extremities (BUE and BLE); This is a spontaneous report from a contactable physician. A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 28Jan2021 16:00 (at the age of 47 years old) at a single dose for covid-19 immunization. Medical history included known allergies: shellfish, seasonal allergies and psoriasis. Concomitant medications included several medications in two weeks. The patient is not pregnant. The patient had no other vaccine in four weeks. On 29Jan2021 23:45, after being asleep for approximately one hour, felt acutely short of breath and anxious, which lasted less than a minute and was then followed by numbness and tingling in her neck - radiating to the pinnae of her ears, bilateral shoulders and to bilateral upper and lower extremities (BUE and BLE). These events resulted in emergency room visit. The patient underwent lab tests and procedures which included PCR/nasal swab on 29Jan2021 (post vaccination) which showed negative. Therapeutic measures were taken as a result of all the events which included diphenhydramine (BENADRYL), IVF. Outcome of all the events was recovering.   Information on the lot/batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: right cervical and axillary lymphadenopathy; This is a spontaneous report received from a contactable nurse (who is also the patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261, expiry date: unknown), via an unspecified route of administration on the right arm, on 27Jan2021 13:15, at single dose, for COVID-19 immunization, at public health department. Medical history included hypertension (HTN), anxiety, depression, myalgia and penicillin allergy (PCN allergy). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. Concomitant medication included losartan; hydrochlorothiazide, triamterene (MAXZIDE); cetirizine; colecalciferol (VITAMIN D); escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2 vaccination. On 29Jan2021, the patient experienced right cervical and axillary lymphadenopathy. No treatment was given for the event. The patient was recovering from the event. The reporter assessed the event as non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: minor injection site soreness; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El324? (as reported)), via an unspecified route of administration at the left arm on 08Jan2021 at 13:00 (01:00 PM) at a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no medical history. The patient had no allergies to medications, food, or other products. Concomitant medication included levothyroxine sodium (UNITHROID) that was received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced minor injection site soreness on Jan2021. The event was reported as non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event was recovered on Jan2021.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Loss of personal independence in daily activities, Migraine
Clinical narrative: chills; fatigue; migraine-like headaches; dizziness; nausea; migraine-like headache and fatigue severe enough to prevent normal activity; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), intramuscularly into the left arm on 28Jan2021 14:15 at a single dose for COVID-19 immunisation. Medical history included Polycystic ovarian syndrome (PCOS), depression, obesity and allergies to latex. Patient was not pregnant. Concomitant medication included duloxetine hydrochloride (CYMBALTA), bupropion hydrochloride (WELLBUTRIN), colecalciferol (VITAMIN D) and cyanocobalamin (VITAMIN B12). The patient previously took tetracycline and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685), intramuscularly into the right arm on 06Jan2021 03:15 PM at a single dose for COVID-19 immunisation. On 28Jan2021 20:00, patient experienced chills, fatigue, migraine-like headaches, dizziness, nausea and migraine-like headache and fatigue severe enough to prevent normal activity. The events were reported as non-serious. The patient did not receive any treatment for the events reported. Outcome of events was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: chills; fatigue; migraine-like headaches; dizziness; nausea; migraine-like headache and fatigue severe enough to prevent normal activity; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), intramuscularly into the left arm on 28Jan2021 14:15 at a single dose for COVID-19 immunisation. Medical history included Polycystic ovarian syndrome (PCOS), depression, obesity and allergies to latex. Patient was not pregnant. Concomitant medication included duloxetine hydrochloride (CYMBALTA), bupropion hydrochloride (WELLBUTRIN), colecalciferol (VITAMIN D) and cyanocobalamin (VITAMIN B12). The patient previously took tetracycline and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685), intramuscularly into the right arm on 06Jan2021 03:15 PM at a single dose for COVID-19 immunisation. On 28Jan2021 20:00, patient experienced chills, fatigue, migraine-like headaches, dizziness, nausea and migraine-like headache and fatigue severe enough to prevent normal activity. The events were reported as non-serious. The patient did not receive any treatment for the events reported. Outcome of events was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This is a spontaneous report from a non-contactable consumer (patient).  A 48-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9262), via an unspecified route of administration on 28Jan2021 at a single dose on the right arm for COVID-19 immunization. Medical history included asthma and postpartum cardiomyopathy on unknown dates and unknown if ongoing. The patient had allergies to sulfa and penicillin. Prior to vaccination, the patient has not had COVID-19. Concomitant medication included fexofenadine hydrochloride (ALLEGRA), carvedilol (manufacturer unknown), cefixime (FLEXERIL), losartan (manufacturer unknown) and montelukast sodium (SINGULAIR). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took Cipro, Biaxin and Ampicillin and allergies. Since the vaccination, the patient has not been tested for COVID. The patient experienced hives on 30Jan2021. The patient did not receive any treatment for the event. The patient has not recovered from the event.   No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Neck pain, Pain, Sinusitis
Clinical narrative: Chills; body aches; head and neck pain; head and neck pain; sinusitis; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in left arm on 29Jan2021 14:00 at a single dose for Covid-19 immunization. Medical history included asthma, and Covid-19 prior to vaccination. Patient was not pregnant. Concomitant medication included bupropion hydrochloride (WELLBUTRIN). The patient previously took erythromycin and had allergy. The patient experienced chills, body aches, head and neck pain, and sinusitis on 29Jan2021. No treatment was given. Patient has not tested for Covid after vaccination. Outcome of the events was recovering.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeling abnormal, Headache
Clinical narrative: I felt extremely achy all over especially in my arms hands neck and back/left arm aches all the way down; I had a headache; felt lightheaded at times/slight dizziness; experienced chills on and off; But I was very tired and it lasted for around 20 hours.; not feeling normal; This is a spontaneous report from a contactable consumer (patient herself). An elderly female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL9262), via an unspecified route of administration on the left arm, first dose on 28Jan2021 09:15 at single dose for COVID-19 vaccination.  Medical history included pre - diabetic and have hypertension, known allergies Yeast and some perfumes Sulfa drugs. Patient is not pregnant. Patient did not have COVID prior to vaccination. Concomitant medication included metformin and losartan. On 28Jan2021, at 08:00 PM, patient felt extremely achy all over especially in her arms hands neck and back. She had a headache and felt lightheaded at times and experienced chills on and off. So she took ibuprofen for extremely achy all over especially in her arms hands neck and back. She had a headache and felt lightheaded at times and experienced chills on and off. But patient also stated that she was very tired and it lasted for around 20 hours. It has been 4 days since the shot and she was not feeling normal in that she have some lightheaded or slight dizziness and her left arm aches all the way down. Patient was not treated for the other events. Patient was not tested post vaccination. The outcome of the events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: I felt extremely achy all over especially in my arms hands neck and back/left arm aches all the way down; I had a headache; felt lightheaded at times/slight dizziness; experienced chills on and off; But I was very tired and it lasted for around 20 hours.; not feeling normal; This is a spontaneous report from a contactable consumer (patient herself). An elderly female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL9262), via an unspecified route of administration on the left arm, first dose on 28Jan2021 09:15 at single dose for COVID-19 vaccination.  Medical history included pre - diabetic and have hypertension, known allergies Yeast and some perfumes Sulfa drugs. Patient is not pregnant. Patient did not have COVID prior to vaccination. Concomitant medication included metformin and losartan. On 28Jan2021, at 08:00 PM, patient felt extremely achy all over especially in her arms hands neck and back. She had a headache and felt lightheaded at times and experienced chills on and off. So she took ibuprofen for extremely achy all over especially in her arms hands neck and back. She had a headache and felt lightheaded at times and experienced chills on and off. But patient also stated that she was very tired and it lasted for around 20 hours. It has been 4 days since the shot and she was not feeling normal in that she have some lightheaded or slight dizziness and her left arm aches all the way down. Patient was not treated for the other events. Patient was not tested post vaccination. The outcome of the events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Vaginal disorder
Clinical narrative: She had a severe vaginal reaction; This is a spontaneous report from a contactable pharmacist. A 51-years-old female patient (nurse)  received  BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown)  via an unspecified route of administration as a  SINGLE DOSE for covid-19 vaccination. The patient medical history and concomitant medications were not reported.  The patient experienced she had a severe vaginal reaction. The nurse  informed the pharmacist that she had used a personal lubricant during intercourse. The pharmacist asked if a common ingredient in the personal lubricant and most cosmetic fillers, hyaluronic acid, could be the culprit for the reaction that was experienced by the nurse. When the patient originally reported the adverse event she did not have the details regarding the use of the lubricant.   The clinical outcome of the event was unknown.  Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for covid before getting her second dose; tested positive for covid before getting her second dose; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at SINGLE DOSE for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported.  The patient received the first dose of the Pfizer vaccine at her workplace. She tested positive for covid before getting her second dose and wanted to know how this will affect the administration. The outcome was unknown.    Information on the Lot/Batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site discomfort
Clinical narrative: Arm pain or discomfort on the injection site; Arm pain or discomfort on the injection site; This is a spontaneous report from a Pfizer-sponsored Program. A contactable consumer (patient) reported that a male patient of an unspecified age received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm pain or discomfort on the injection site. The patient reported it was not severe, he just wanted to know if he can take Tylenol or Advil. Outcome of the events was unknown.  Information of lot/batch number has been requested.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Fatigue, Headache
Clinical narrative: Chills; stabbing headache; low grade fever (100.4F); body aches; dry cough; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 66-year-old male patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, formulation: Solution for injection, Lot number: EN5318) via unspecified route of administration, on right arm, at 08:15 on 24Jan2021 at single dose for COVID-19 immunization. The patient medical history included childhood asthma, lymphomatoid papulosis, small fiber neuropathy, canker sores on tongue, allergies to penicillin, eggplant, quinoa. The concomitant medication was not reported. The patient previously took celecoxib (CELEBREX) and experienced allergies. The patient experienced chills followed by stabbing headache, low grade fever (100.4F), body aches, dry cough and fatigue at 21:00 on 29Jan2021. It was reported that symptoms lessened within 24 hours and after 48 hours only cough and fatigue remained. It was reported that as of 01Feb2021, the patient had only occasional cough and some fatigue. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient had not received any treatment for the events. The events were reported as non-serious. The patient had not diagnosed with COVID-19 prior to vaccination and had not been rested for COVID-19 since the vaccination. The outcome of the events chills, stabbing headache, low grade fever (100.4F), body aches was recovering, while for fatigue and dry cough was not recovered.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Chills; stabbing headache; low grade fever (100.4F); body aches; dry cough; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 66-year-old male patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, formulation: Solution for injection, Lot number: EN5318) via unspecified route of administration, on right arm, at 08:15 on 24Jan2021 at single dose for COVID-19 immunization. The patient medical history included childhood asthma, lymphomatoid papulosis, small fiber neuropathy, canker sores on tongue, allergies to penicillin, eggplant, quinoa. The concomitant medication was not reported. The patient previously took celecoxib (CELEBREX) and experienced allergies. The patient experienced chills followed by stabbing headache, low grade fever (100.4F), body aches, dry cough and fatigue at 21:00 on 29Jan2021. It was reported that symptoms lessened within 24 hours and after 48 hours only cough and fatigue remained. It was reported that as of 01Feb2021, the patient had only occasional cough and some fatigue. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient had not received any treatment for the events. The events were reported as non-serious. The patient had not diagnosed with COVID-19 prior to vaccination and had not been rested for COVID-19 since the vaccination. The outcome of the events chills, stabbing headache, low grade fever (100.4F), body aches was recovering, while for fatigue and dry cough was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: 9 days after first dose had a PCR test for Covid-19 and she received her positive results; This is a spontaneous report from a Pfizer sponsored program Pfizer First Connect via a contactable consumer. A 93-year-old female patient (consumer's mother) received the first dose of bnt162b2 (PFIZER COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunisation. The medical history and concomitant medications were not reported. 9 days after first dose the patient had a PCR test for covid-19 and she received her positive results in Jan2021. The outcome of the event was unknown.  Information about Lot/Batch has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Caller stated she tested positive for covid the night of the first dose of the vaccine; This is a spontaneous report from a contactable nurse. This (Age: 25; Unit: Unknown) female Nurse (patient) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patient tested positive for COVID the night of the first dose of the vaccine. The outcome of the event was unknown.  Information on the lot/ batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (daughter) received 1st dose of BNT162B2 on 15Jan2021 at singe dose for Covid-19 Immunisation. Medical history and concomitant drug were not reported. She got her first dose of the vaccine on 15Jan2021 and then tested positive for COVID on the 24Jan2021. She is wondering how long daughter has to wait to receive her 2nd dose of the COVID vaccine. Outcome of the events was unknown.  Information on Lot/Batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid/positive results for COVID/she felt symptoms; This is a spontaneous report from a contactable consumer. This 34-year-old female consumer (patient) reported that she received the first dose of bnt162b2 (BNT162B2, Batch/lot number: EL1283) , via an unspecified route of administration at left arm on 14Jan2021 at single dose for covid-19 immunization.  Medical history was none.  The patient's concomitant medications were not reported.  The patient experienced tested positive for covid/positive results for covid on 16Jan2021 with outcome of unknown. Consumer states that she might have had COVID prior to getting her first dose and just did not know it, because after the first dose she felt symptoms and got positive results for COVID on 16Jan2021. She stated that she was on day 16 of quarantine, and she had her last COVID results four or 5 days ago (Jan2021), and it was positive. She stated that she got her last test on Saturday (30Jan2021), but did not have the results yet. She had no other vaccines on the same day as the COVID vaccine.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for Covid/positive results for COVID/she felt symptoms; This is a spontaneous report from a contactable consumer. This 34-year-old female consumer (patient) reported that she received the first dose of bnt162b2 (BNT162B2, Batch/lot number: EL1283) , via an unspecified route of administration at left arm on 14Jan2021 at single dose for covid-19 immunization.  Medical history was none.  The patient's concomitant medications were not reported.  The patient experienced tested positive for covid/positive results for covid on 16Jan2021 with outcome of unknown. Consumer states that she might have had COVID prior to getting her first dose and just did not know it, because after the first dose she felt symptoms and got positive results for COVID on 16Jan2021. She stated that she was on day 16 of quarantine, and she had her last COVID results four or 5 days ago (Jan2021), and it was positive. She stated that she got her last test on Saturday (30Jan2021), but did not have the results yet. She had no other vaccines on the same day as the COVID vaccine.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program Pfizer First Connect. A female patient of an unspecified age receive their first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on 14Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that after the first dose, the patient tested positive for covid on an unspecified date in Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Jan2021. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program Pfizer First Connect. A female patient of an unspecified age receive their first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on 14Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that after the first dose, the patient tested positive for covid on an unspecified date in Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Jan2021. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pain, SARS-CoV-2 test positive
Clinical narrative: had mild symptoms chills; body ache; This is a spontaneous report from a contactable nurse (patient). This 45-year-old patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route on 29Jan2021 at 14:00 (at the age of 45-years-old) as a single dose for COVID-19 immunization. Medical history included COVID-19 in April2020 and a positive COVID-19 test on 28Jan2021. Concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced mild symptoms, chills and body aches. On Saturday (30Jan2021) the patient didn't go to work. The patient was concerned because she found out after receiving the vaccine that she had COVID-19 when she received the vaccine. She wanted to know if there were any issues regarding her health with being positive and having gotten the vaccine. The outcome of mild symptoms, chills, and body aches was recovered on Sunday (31Jan2021).   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chills, Pyrexia, SARS-CoV-2 test
Clinical narrative: had mild symptoms chills; body ache; This is a spontaneous report from a contactable nurse (patient). This 45-year-old patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route on 29Jan2021 at 14:00 (at the age of 45-years-old) as a single dose for COVID-19 immunization. Medical history included COVID-19 in April2020 and a positive COVID-19 test on 28Jan2021. Concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced mild symptoms, chills and body aches. On Saturday (30Jan2021) the patient didn't go to work. The patient was concerned because she found out after receiving the vaccine that she had COVID-19 when she received the vaccine. She wanted to know if there were any issues regarding her health with being positive and having gotten the vaccine. The outcome of mild symptoms, chills, and body aches was recovered on Sunday (31Jan2021).   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pain, SARS-CoV-2 test positive
Clinical narrative: chills; low grade temperature; positive for COVID-19; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. Medical history included COVID-19 from Apr2020. Concomitant medications were not reported. On 29Jan2019, the patient tested positive for Covid-19. She reported that on 30Jan2021 she did not go to work because she had onset of the same symptoms that she experienced with COVID-19 in Apr2020, which were chills, low grade temperature that was not that bad, except for shortness of breath. She did not have shortness of breath this time. She felt like she had COVID-19 all over again starting 30Jan2021. On 31Jan2021, around 14:00, sehe reported that everything subsided, all the symptoms of COVID-19 stopped and were gone now, she has no symptoms. She was not allowed to work due to the COVID-19 positive result. The outcome of the events chills and low grade temperature was recovered on an unspecified date. The outcome of the event Covid-19 was unknown.  Information about Lot/Batch has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chills, Pyrexia, SARS-CoV-2 test
Clinical narrative: chills; low grade temperature; positive for COVID-19; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. Medical history included COVID-19 from Apr2020. Concomitant medications were not reported. On 29Jan2019, the patient tested positive for Covid-19. She reported that on 30Jan2021 she did not go to work because she had onset of the same symptoms that she experienced with COVID-19 in Apr2020, which were chills, low grade temperature that was not that bad, except for shortness of breath. She did not have shortness of breath this time. She felt like she had COVID-19 all over again starting 30Jan2021. On 31Jan2021, around 14:00, sehe reported that everything subsided, all the symptoms of COVID-19 stopped and were gone now, she has no symptoms. She was not allowed to work due to the COVID-19 positive result. The outcome of the events chills and low grade temperature was recovered on an unspecified date. The outcome of the event Covid-19 was unknown.  Information about Lot/Batch has been requested.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: His father got his first covid vaccine shot in (place) and 5 days after he was tested positive with covid 19 but did not get any symptoms.; This is a spontaneous report from a non-contactable consumer. This consumer reported on behalf of his father.  A male patient of an unspecified age received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient got his first COVID vaccine shot in and 5 days after he was tested positive with COVID 19 but did not get any symptoms. Asking if his father could get the second COVID vaccine shot. Outcome of the event was unknown.   No follow-up attempts are possible, Information about batch/lot number cannot be obtained.